The anti-inflammatory and anti-nociceptive effects of disodium glycyrrhetinic acid
hemiphthalate (glycyrrhetinic acid 3β-O-hemiphthalate sodium) after parenteral administration were determined in several
animal models. Disodium glycyrrhetinic acid hemiphthalate (GAP) significantly inhibited
the rat paw edema induced by carrageenin (ID50 = 21.37 mg/kg), and mice writhing responses caused by acetic acid (ID50 = 9.12 mg/kg). The potency of disodium glycyrrhetinic acid hemiphthalate was about
13.05 times higher than acetylsalicylic acid in inhibiting rat paw edema and 12.84
times higher in inhibiting abdominal constrictions in mice.
Non-steroidal anti-inflammatory agents - anti-nociceptive - carrageenin - glycyrrhetinic
acid derivatives